Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (170)	4/21/1998 9:11:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 641

Sonki, I own both stocks too. Used to own WLA but sold too soon. I expect these three pharms to continue to do well in the short and long term. P/E are high (for PFE and WLA, not LLY) but considering their consistent growth rate and potential, not too outrageous, IMHO. No Asian flu effect here and no nasty earnings shortfall preannouncement. However, I sort of have a nagging feeling that PFE may have a big correction sometime in the next few months on news about side effects from people who are "abusing" the drug. That will present another buying opportunity for those who've missed the boat. I expect a good day for the drug stocks tomorrow.